{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:51:29Z","timestamp":1794027089372,"version":"4.8.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"am","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA264619"],"award-info":[{"award-number":["CA264619"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["P2ZHP3-199648"],"award-info":[{"award-number":["P2ZHP3-199648"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["P500PM_210917"],"award-info":[{"award-number":["P500PM_210917"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["874839"],"award-info":[{"award-number":["874839"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research Bonn Office","doi-asserted-by":"publisher","award":["16LW0243K"],"award-info":[{"award-number":["16LW0243K"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009318","name":"Helmholtz Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004189","name":"Max-Planck-Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100024144","name":"Bears Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024144","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100027545","name":"Chicago Bears","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100027545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100028926","name":"Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100028926","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["ALTF 399-2021"],"award-info":[{"award-number":["ALTF 399-2021"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ccell.2025.06.004","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T12:05:29Z","timestamp":1750939529000},"page":"1495-1511.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression"],"prefix":"10.1016","volume":"43","author":[{"given":"Lisa","family":"Schweizer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary A.","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Kelliher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes J.","family":"Bilecz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janna","family":"Heide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonhard","family":"Donle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aasa","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Metousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry M.","family":"Nordmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian A.","family":"Rosenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian T.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine C.","family":"Kurnit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Thielert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes B.","family":"M\u00fcller-Reif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Diane","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian J.","family":"Theis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Mund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo R.","family":"Lastra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8624-1507","authenticated-orcid":false,"given":"Ernst","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2025.06.004_bib1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ygyno.2019.12.033","article-title":"Low-grade serous ovarian cancer: State of the science","volume":"156","author":"Slomovitz","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ccell.2025.06.004_bib2","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/ijgc-2024-005305","article-title":"Molecular changes driving low-grade serous ovarian cancer and implications for treatment","volume":"34","author":"Kelliher","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ccell.2025.06.004_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ygyno.2009.03.001","article-title":"Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant","volume":"114","author":"Gershenson","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ccell.2025.06.004_bib4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/AOG.0000000000004173","article-title":"Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment","volume":"137","author":"Kurnit","year":"2021","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ccell.2025.06.004_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: A mutational analysis with immunohistochemical correlation","volume":"29","author":"Singer","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ccell.2025.06.004_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ygyno.2019.06.011","article-title":"PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent\/metastatic low-grade ovarian cancers and serous borderline ovarian tumors","volume":"154","author":"Tang","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ccell.2025.06.004_bib7","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1158\/0008-5472.CAN-04-2067","article-title":"Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors","volume":"64","author":"Ho","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.06.004_bib8","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1158\/1541-7786.MCR-08-0193","article-title":"Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors","volume":"6","author":"Anglesio","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ccell.2025.06.004_bib9","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1158\/1078-0432.CCR-21-4183","article-title":"MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma","volume":"28","author":"Manning-Geist","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2025.06.004_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.humpath.2022.04.008","article-title":"Precursors in the ovarian stroma: another pathway to explain the origin of ovarian serous neoplasms","volume":"127","author":"Silva","year":"2022","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ccell.2025.06.004_bib11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/PAS.0000000000000824","article-title":"Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases","volume":"41","author":"Vang","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ccell.2025.06.004_bib12","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ccell.2025.06.004_bib13","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41587-022-01302-5","article-title":"Deep Visual Proteomics defines single-cell identity and heterogeneity","volume":"40","author":"Mund","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2025.06.004_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajpath.2020.09.006","article-title":"The Origin of Ovarian Cancer Species and Precancerous Landscape","volume":"191","author":"Shih","year":"2021","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ccell.2025.06.004_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cels.2020.04.003","article-title":"nucleAIzer: A Parameter-free Deep Learning Framework for Nucleus Segmentation Using Image Style Transfer","volume":"10","author":"Hollandi","year":"2020","journal-title":"Cell Syst."},{"key":"10.1016\/j.ccell.2025.06.004_bib16","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.cels.2023.10.003","article-title":"A framework for ultra-low-input spatial tissue proteomics","volume":"14","author":"Makhmut","year":"2023","journal-title":"Cell Syst."},{"key":"10.1016\/j.ccell.2025.06.004_bib17","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41586-024-08061-0","article-title":"Spatial proteomics identifies JAKi as treatment for a lethal skin disease","volume":"635","author":"Nordmann","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.06.004_bib18","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/ijc.24465","article-title":"APM2 is a novel mediator of cisplatin resistance in a variety of cancer cell types regardless of p53 or MMR status","volume":"125","author":"Scott","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ccell.2025.06.004_bib19","doi-asserted-by":"crossref","first-page":"37663","DOI":"10.18632\/oncotarget.5438","article-title":"Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes","volume":"6","author":"Hunter","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccell.2025.06.004_bib20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13148-019-0785-z","article-title":"ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p\/NEDD9 axis in breast cancer","volume":"11","author":"Wang","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.ccell.2025.06.004_bib21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.7150\/jca.17579","article-title":"The NOR1\/OSCP1 proteins in cancer: from epigenetic silencing to functional characterization of a novel tumor suppressor","volume":"8","author":"Yi","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.ccell.2025.06.004_bib22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/PAS.0b013e318212ae22","article-title":"The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer","volume":"35","author":"King","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ccell.2025.06.004_bib23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ygyno.2021.11.019","article-title":"The genomic landscape of low-grade serous ovarian\/peritoneal carcinoma and its impact on clinical outcomes","volume":"165","author":"Gershenson","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ccell.2025.06.004_bib24","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.3892\/ijo.2016.3744","article-title":"ADAM17 promotes epithelial-mesenchymal transition via TGF-beta\/Smad pathway in gastric carcinoma cells","volume":"49","author":"Xu","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ccell.2025.06.004_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi4613","article-title":"Transforming growth factor-beta1 in regulatory T cell biology","volume":"7","author":"Moreau","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ccell.2025.06.004_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ygyno.2019.11.029","article-title":"Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma","volume":"157","author":"Llaurado Fernandez","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ccell.2025.06.004_bib27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.neuron.2018.12.019","article-title":"Differential NOVA2-Mediated Splicing in Excitatory and Inhibitory Neurons Regulates Cortical Development and Cerebellar Function","volume":"101","author":"Saito","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.ccell.2025.06.004_bib28","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/jnr.20849","article-title":"Neudesin, a secreted factor, promotes neural cell proliferation and neuronal differentiation in mouse neural precursor cells","volume":"83","author":"Kimura","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ccell.2025.06.004_bib29","first-page":"501","article-title":"P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas","volume":"39","author":"Zou","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ccell.2025.06.004_bib30","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nmeth.4077","article-title":"OmniPath: guidelines and gateway for literature-curated signaling pathway resources","volume":"13","author":"Turei","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2025.06.004_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19124122","article-title":"S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer","volume":"19","author":"Noye","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ccell.2025.06.004_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10029","article-title":"A molecular ruler regulates cytoskeletal remodelling by the Rho kinases","volume":"6","author":"Truebestein","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.06.004_bib33","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1158\/0008-5472.CAN-08-1645","article-title":"Membrane type 1 matrix metalloproteinase-mediated stromal syndecan-1 shedding stimulates breast carcinoma cell proliferation","volume":"68","author":"Su","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.06.004_bib34","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1172\/JCI33775","article-title":"The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin","volume":"118","author":"Kenny","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ccell.2025.06.004_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1238051","article-title":"CD147: an integral and potential molecule to abrogate hallmarks of cancer","volume":"13","author":"Nyalali","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ccell.2025.06.004_bib36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.trecan.2018.11.003","article-title":"Gluconeogenesis in Cancer: Function and Regulation of PEPCK, FBPase, and G6Pase","volume":"5","author":"Wang","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ccell.2025.06.004_bib37","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41586-019-1173-8","article-title":"Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts","volume":"569","author":"Eckert","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.06.004_bib38","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/sj.bjc.6605280","article-title":"KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma","volume":"101","author":"White","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2025.06.004_bib39","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/ng.3844","article-title":"Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL\/HERVL retrotransposons","volume":"49","author":"Hendrickson","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2025.06.004_bib40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1158\/0008-5472.CAN-21-1467","article-title":"Neoadjuvant Chemotherapy Induces Genomic and Transcriptomic Changes in Ovarian Cancer","volume":"82","author":"Javellana","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.06.004_bib41","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.06.004_bib42","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1200\/JCO.22.01900","article-title":"Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study","volume":"41","author":"Matulonis","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.06.004_bib43","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-020-02015-1","article-title":"MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data","author":"Argelaguet","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2025.06.004_bib44","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2025.06.004_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111838","article-title":"A molecular atlas of the human postmenopausal fallopian tube and ovary from single-cell RNA and ATAC sequencing","volume":"41","author":"Lengyel","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2025.06.004_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100643","article-title":"A standardized and reproducible workflow for membrane glass slides in routine histology and spatial proteomics","volume":"22","author":"Nordmann","year":"2023","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ccell.2025.06.004_bib47","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/s41592-023-02007-6","article-title":"Spatial single-cell mass spectrometry defines zonation of the hepatocyte proteome","volume":"20","author":"Rosenberger","year":"2023","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2025.06.004_bib48","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.pas.0000164030.82810.db","article-title":"Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up","volume":"29","author":"Longacre","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ccell.2025.06.004_bib49","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1158\/0008-5472.CAN-16-2224","article-title":"EIF1AX and NRAS Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas","volume":"77","author":"Etemadmoghadam","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.06.004_bib50","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2025.06.004_bib51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41568-023-00634-x","article-title":"Eph receptors and ephrins in cancer progression","volume":"24","author":"Pasquale","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.06.004_bib52","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ygyno.2023.03.011","article-title":"Effect of bevacizumab in advanced low grade serous ovarian cancer: Data from the MITO 22 trial","volume":"172","author":"Musacchio","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ccell.2025.06.004_bib53","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1091\/mbc.e17-02-0126","article-title":"alpha5beta1-Integrin promotes tension-dependent mammary epithelial cell invasion by engaging the fibronectin synergy site","volume":"28","author":"Miroshnikova","year":"2017","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ccell.2025.06.004_bib54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.06.004_bib55","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1158\/0008-5472.CAN-06-1147","article-title":"c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion","volume":"67","author":"Sawada","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.06.004_bib56","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1172\/JCI74778","article-title":"Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion","volume":"124","author":"Kenny","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ccell.2025.06.004_bib57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ygyno.2024.06.008","article-title":"Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilities","volume":"188","author":"Manning-Geist","year":"2024","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ccell.2025.06.004_bib58","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1056\/NEJMoa2309169","article-title":"Mirvetuximab Soravtansine in FRalpha-Positive, Platinum-Resistant Ovarian Cancer","volume":"389","author":"Moore","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.06.004_bib59","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2025.06.004_bib60","doi-asserted-by":"crossref","DOI":"10.15252\/msb.202110798","article-title":"Ultra-high sensitivity mass spectrometry quantifies single-cell proteome changes upon perturbation","volume":"18","author":"Brunner","year":"2022","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.ccell.2025.06.004_bib61","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","article-title":"DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput","volume":"17","author":"Demichev","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2025.06.004_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100082","article-title":"A New Parallel High-Pressure Packing System Enables Rapid Multiplexed Production of Capillary Columns","volume":"20","author":"Muller-Reif","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ccell.2025.06.004_bib63","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41592-020-00998-0","article-title":"diaPASEF: parallel accumulation-serial fragmentation combined with data-independent acquisition","volume":"17","author":"Meier","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2025.06.004_bib64","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1038\/s41467-022-31492-0","article-title":"dia-PASEF data analysis using FragPipe and DIA-NN for deep proteomics of low sample amounts","volume":"13","author":"Demichev","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.06.004_bib65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13059-021-02577-8","article-title":"MUON: multimodal omics analysis framework","volume":"23","author":"Bredikhin","year":"2022","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2025.06.004_bib66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jmoldx.2016.07.012","article-title":"Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays","volume":"19","author":"Kadri","year":"2017","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.ccell.2025.06.004_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput. Biol."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825002533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825002533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T05:22:28Z","timestamp":1767158548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610825002533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1535610825002533"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2025.06.004","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.11.13.23298409","asserted-by":"object"}]},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2025.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}